Effect of intraperitoneal and intravenous administration of cholecystokinin-8 and apolipoprotein AIV on intestinal lymphatic CCK-8 and apo AIV concentration

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 296, Issue 1, 2009, Pages

  Lo, Chun Min ^a   Xu, Min ^a   Yang, Qing ^a   Zheng, Shuqin ^a   Carey, Katherine M ^a   Tubb, Matthew R ^a   Davidson, W Sean ^a   Liu, Min ^a   Woods, Stephen C ^a   Tso, Patrick ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Aminopeptidase; Dipeptidyl peptidase IV; Lymph; Plasma

Indexed keywords

AMINOPEPTIDASE; APOLIPOPROTEIN A4; CHOLECYSTOKININ; CHOLECYSTOKININ OCTAPEPTIDE; DIPEPTIDYL PEPTIDASE IV; FAT; PEPTIDE; RECOMBINANT APOLIPOPROTEIN A4; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DEGRADATION; DIET RESTRICTION; DRUG ADMINISTRATION ROUTE; DRUG EFFICACY; ENZYME ACTIVITY; FOOD INTAKE; INTESTINE; LAMINA PROPRIA; LIPID ABSORPTION; LYMPH FLOW; LYMPH VESSEL; MALE; NONHUMAN; PLASMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; RAT; SATIETY; SPRAGUE DAWLEY RAT;

AMINOPEPTIDASES; ANIMALS; ANTIGENS, CD26; APOLIPOPROTEINS A; APPETITE DEPRESSANTS; CHOLECYSTOKININ; DOSE-RESPONSE RELATIONSHIP, DRUG; EATING; INJECTIONS, INTRAPERITONEAL; INJECTIONS, INTRAVENOUS; INTESTINES; LYMPH; MALE; PEPTIDE FRAGMENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TIME FACTORS;

EID: 58149511946     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.90410.2008     Document Type: Article

References (53)

1. Banegas I, Prieto I, Vives F, Alba F, Duran R, Segarra AB, de Gasparo M, Ramirez M. Plasma aminopeptidase activities in rats after left and right intrastriatal administration of 6-hydroxydopamine. Neuroendocrinology 80: 219-224, 2004.
2. Barrowman JA, Tso P. Gastrointestinal lymphatics. In: Handbook of Physiology: The Gastrointestinal System. Motility and Circulation. Bethesda, MD: Am. Physiol. Soc., 1989, sect. 6, vol. I, pt. 2, chapt. 48, p. 1733-1777.
3. Beisiegel U, Utermann G. An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterisation. Eur J Biochem 93: 601-608, 1979.
4. Cano V, Ezquerra L, Ramos MP, Ruiz-Gayo M. Characterization of the role of endogenous cholecystokinin on the activity of the paraventricular nucleus of the hypothalamus in rats. Br J Pharmacol 140: 964-970, 2003.
5. Cantor P, Rehfeld JF. Radioimmunoassay of cholecystokinin: comparison of different tracers. J Immunol Methods 82: 47-55, 1985.
6. Costa M, Furness JB, Llewellyn-Smith IJ. Histochemistry of the enteric nervous system. In: Physiology of the Gastrointestinal Tract, edited by Johnson LR, Christensen J, Jackson MJ, Jacobson ED, and Walsh JH. New York: Raven Press, 1987, p. 1-3.
7. Curry SH, McCarthy D, Morris CF, Simpson-Heren L. Whole body autoradiography of CCK-8 in rats. Regul Pept 55: 179-188, 1995.
8. Deiling DA. Mechanism of pancreatic exocrine secretion. Am J Gastroenterol 52: 17-24, 1969.
9. DeLamatre JG, Roheim PS. The response of apolipoprotein A-IV to cholesterol feeding in rats. Biochim Biophys Acta 751: 210-217, 1983.
10. Deschenes RJ, Lorenz LJ, Haun RS, Roos BA, Collier KJ, Dixon JE. Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin. Proc Natl Acad Sci USA 81: 726-730, 1984.
11. Deschodt-Lanckman M, Bui ND. Cholecystokinin octa- and tetrapeptide degradation by synaptic membranes. I. Evidence for competition with enkephalins for in vitro common degradation pathways. Peptides 2 Suppl 2: 113-118, 1981.
12. Doi T, Liu M, Seeley RJ, Woods SC, Tso P. Effect of leptin on intestinal apolipoprotein AIV in response to lipid feeding. Am J Physiol Regul Integr Comp Physiol 281: R753-R759, 2001.
13. Fidge NH. The redistribution and metabolism of iodinated apolipoprotein-A-4 in rats. Biochim Biophys Acta 619: 129-141, 1980.
14. Flessner MF, Dedrick RL, Reynolds JC. Bidirectional peritoneal transport of immunoglobulin in rats: tissue concentration profiles. Am J Physiol Renal Fluid Electrolyte Physiol 263: F15-F23, 1992.
15. Fujimoto K, Cardelli JA, Tso P. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am J Physiol Gastrointest Liver Physiol 262: G1002-G1006, 1992.
16. Fukagawa K, Gou HM, Wolf R, Tso P. Circadian rhythm of serum and lymph apolipoprotein AIV in ad libitum-fed and fasted rats. Am J Physiol Regul Integr Comp Physiol 267: R1385-R1390, 1994.
17. Ghiselli G, Crump WL, III, Gotto AM Jr. Binding of apoA-IV-phospholipid complexes to plasma membranes of rat liver. Biochem Biophys Res Commun 139: 122-128, 1986.
18. Gibbs J, Smith GP. Cholecystokinin and satiety: problems in brain-gut interactions. Brain-Gut Interaction, edited by Tache Y and Wingate D, Boca Raton, FL: CRC, 1991, p 255-262.
19. Gibbs J, Young RC, Smith GP. Cholecystokinin decreases food intake in rats. J Comp Physiol Psychol 84: 488-495, 1973.
20. Green PH, Glickman RM, Saudek CD, Blum CB, Tall AR. Human intestinal lipoproteins. Studies in chyluric subjects. J Clin Invest 64: 233-242, 1979.
21. Greenberg D, Smith GP, Gibbs J. Infusion of CCK-8 into hepatic-portal vein fails to reduce food intake in rats. Am J Physiol Regul Integr Comp Physiol 252: R1015-R1018, 1987.
22. Harper AA, Raper HS. Pancreozymin, a stimulant of the secretion of pancreatic enzymes in extracts of the small intestine. J Physiol 102: 115-125, 1943.
23. Hayashi H, Nutting DF, Fujimoto K, Cardelli JA, Black D, Tso P. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J Lipid Res 31: 1613-1625, 1990.
24. Houpt TR. The sites of action of cholecystokinin in decreasing meal size in pigs. Physiol Behav 31: 693-698, 1983.
25. Ivy AC, Oldberg E. A hormone mechanism for gallbladder contraction and evacuation. Am J Physiol 86: 599-613, 1928.
26. Kadar T, Penke B, Kovacs K, Telegdy G. Depression of rat feeding in familiar and novel environment by sulfated and nonsulfated cholecystokinin octapeptide. Physiol Behav 34: 395-400, 1985.
27. Kalogeris TJ, Fukagawa K, Tsuchiya T, Qin X, Tso P. Intestinal synthesis and lymphatic secretion of apolipoprotein A-IV after cessation of duodenal fat infusion: mediation by bile. Biochim Biophys Acta 1436: 451-466, 1999.
28. Kobelt P, Paulitsch S, Goebel M, Stengel A, Schmidtmann M, van dV, I, Tebbe JJ, Veh RW, Klapp BF, Wiedenmann B, Tache Y, Monnikes H. Peripheral injection of CCK-8S induces Fos expression in the dorsomedial hypothalamic nucleus in rats. Brain Res 1117: 109-117, 2006.
29. Kolehmainen L, Mikola J. Partial purification and enzymatic properties of an aminopeptidase from barley. Arch Biochem Biophys 145: 633-642, 1971.
30. Koulischer D, Moroder L, Deschodt-Lanckman M. Degradation of cholecystokinin octapeptide, related fragments and analogs by human and rat plasma in vitro. Regul Pept 4: 127-139, 1982.
31. Kraly FS, Carty WJ, Resnick S, Smith GP. Effect of cholecystokinin on meal size and intermeal interval in the sham-feeding rat. J Comp Physiol Psychol 92: 697-707, 1978.
32. Lacourse KA, Friis-Hansen L, Samuelson LC, Rehfeld JF. Altered processing of procholecystokinin in carboxypeptidase E-deficient fat mice: differential synthesis in neurons and endocrine cells. FEBS Lett 436: 61-66, 1998.
33. Lefevre M, Roheim PS. Metabolism of apolipoprotein A-IV. J Lipid Res 25: 1603-1610, 1984.
34. Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA. Cholecystokinin bioactivity in human plasma. Molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 75: 1144-1152, 1985.
35. Liddle RA, Goldfine ID, Williams JA. Bioassay of plasma cholecystokinin in rats: effects of food, trypsin inhibitor, and alcohol. Gastroenterology 87: 542-549, 1984.
36. Liu M, Maiorano N, Shen L, Pearson K, Tajima D, Zhang DM, Woods SC, Seeley RJ, Davidson WS, Tso P. Expression of biologically active rat apolipoprotein AIV in Escherichia coli. Physiol Behav 78: 149-155, 2003.
37. Lo CM, Zhang DM, Pearson K, Ma L, Sun W, Sakai RR, Davidson WS, Liu M, Raybould HE, Woods SC, Tso P. Interaction of apolipoprotein AIV with cholecystokinin on the control of food intake. Am J Physiol Regul Integr Comp Physiol 293: R1490-R1494, 2007.
38. Lukas G, Brindle SD, Greengard P. The route of absorption of intraperitoneally administered compounds. J Pharmacol Exp Ther 178: 562-564, 1971.
39. Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept 85: 9-24, 1999.
40. Moran TH, Smith GP, Hostetler AM, McHugh PR. Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain Res 415: 149-152, 1987.
41. Muller K, Hsiao S. Specificity of cholecystokinin satiety effect: reduction of food but not water itnake. Pharmacol Biochem Behav 6: 643-646, 1977.
42. Nagatsu T, Hino M, Fuyamada H, Hayakawa T, Sakakibara S. New chromogenic substrates for X-prolyl dipeptidyl-aminopeptidase. Anal Biochem 74: 466-476, 1976.
43. Nagy JA. Lymphatic and nonlymphatic pathways of peritoneal absorption in mice: physiology versus pathology. Blood Purif 10: 148-162, 1992.
44. Raybould HE, Meyer JH, Tabrizi Y, Liddle RA, Tso P. Inhibition of gastric emptying in response to intestinal lipid is dependent on chylomicron formation. Am J Physiol Regul Integr Comp Physiol 274: R1834-R1838, 1998.
45. Rehfeld JF. Immunochemical studies on cholecystokinin. II. Distribution and molecular heterogeneity in the central nervous system and small intestine of man and hog. J Biol Chem 253: 4022-4030, 1978.
46. Rehfeld JF, Hansen HF. Characterization of preprocholecystokinin products in the porcine cerebral cortex. Evidence of different processing pathways. J Biol Chem 261: 5832-5840, 1986.
47. Rehfeld JF, Sun G, Christensen T, Hillingso JG. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab 86: 251-258, 2001.
48. Sayegh AI, Ritter RC. Cholecystokinin activates specific enteric neurons in the rat small intestine. Peptides 24: 237-244, 2003.
49. Schneider LH, Murphy RB, Smith GP. Two proglumide analogues are equipotent antagonists of the inhibition of food intake by CCK-8. Peptides 9 Suppl 1: 207-214, 1988.
50. Stein LJ, Woods SC. Cholecystokinin and bombesin act independently to decrease food intake in the rat. Peptides 2: 431-436, 1981.
51. Torregrossa AM, Smith GP. Two effects of high-fat diets on the satiating potency of cholecystokinin-8. Physiol Behav 78: 19-25, 2003.
52. Webb T, Gulley S, Pruitt F, Esdaile AR, Sharma SK, Cox JE, Smith GP, Sayegh AI. Cholecystokinin-8 increases Fos-like immunoreactivity in myenteric neurons of the duodenum and jejunum more after intraperitoneal than after intravenous injection. Neurosci Lett 389: 157-162, 2005.
53. Zhu L, Tamvakopoulos C, Xie D, Dragovic J, Shen X, Fenyk-Melody JE, Schmidt K, Bagchi A, Griffin PR, Thornberry NA, Sinha RR. The role of dipeptidyl peptidase IV in the cleavage of glucagon family peptides: in vivo metabolism of pituitary adenylate cyclase activating polypeptide-(1-38). J Biol Chem 278: 22418-22423, 2003.